Published in N Engl J Med on October 15, 1998
Antioxidant Supplementation in Patients With Kashin-Beck Disease | NCT00376025
Association study of polymorphisms in selenoprotein genes and Kashin-Beck disease and serum selenium/iodine concentration in a Tibetan population. PLoS One (2013) 0.86
Serum thyroglobulin, a biomarker for iodine deficiency, is not associated with increased risk of upper gastrointestinal cancers in a large Chinese cohort. Int J Cancer (2011) 0.77
Serum levels of M-CSF, RANKL and OPG in rats fed with Kashin-Beck disease-affected diet. J Orthop Surg Res (2014) 0.75
Is there a therapeutic role for selenium in alpha-1 antitrypsin deficiency? Nutrients (2013) 0.75
Magnetic resonance imaging in the tibial epiphyseal growth plate development of Wistar rat. J Orthop Surg Res (2014) 0.75
Kashin-Beck osteoarthropathy in rural Tibet in relation to selenium and iodine status. N Engl J Med (1998) 2.09
Disclosure of authors' conflicts of interest: a follow-up. N Engl J Med (2000) 3.16
Studies of thyrotropin physiology by means of radioimmunoassay. Recent Prog Horm Res (1967) 2.48
Treatment of primary hyperparathyroidism. N Engl J Med (1999) 1.97
Increased serum prolactin after administration of synthetic thyrotropin releasing hormone (TRH) in man. J Clin Endocrinol Metab (1971) 1.96
Maternal hypothyroidism and fetal development. N Engl J Med (1999) 1.92
Response to thyrotropin releasing hormone (TRH) in normal man. J Clin Endocrinol Metab (1972) 1.82
Inhibition of thyrotropin response to thyrotropin-releasing hormone by small quantities of thyroid hormones. J Clin Invest (1972) 1.77
Hypothyroidism in workers exposed to polybrominated biphenyls. N Engl J Med (1980) 1.73
The effect of glucocorticoids on thyrotropin secretion. J Clin Invest (1969) 1.61
Iodothyronine metabolism in rat liver homogenates. J Clin Invest (1978) 1.56
Triiodothyronine radioimmunoassay. J Clin Invest (1972) 1.54
Thyrotropin-releasing hormone: regional distribution in rat brain. Science (1974) 1.45
Synthetic thyrotropin-releasing hormone. A potent stimulator of thyrotropin secretion in man. N Engl J Med (1971) 1.40
The need for more vitamin D. N Engl J Med (1998) 1.40
Hyperthyroidism and excessive thyrotropin secretion. N Engl J Med (1972) 1.37
Thyroidal and peripheral production of thyroid hormones. Review of recent findings and their clinical implications. Ann Intern Med (1977) 1.33
Inappropriate antidiuresis and carcinoma of the lung: detection of arginine vasopressin in tumor extracts by immunoassay. J Clin Endocrinol Metab (1966) 1.23
Thyrotropin response to thyrotropin releasing hormone in normal females over forty. J Clin Endocrinol Metab (1972) 1.23
Thyrotropin-releasing hormone in specific nuclei of rat brain. Science (1974) 1.19
Reduction in extrathyroidal triiodothyronine production by propylthiouracil in man. J Clin Invest (1975) 1.19
Regulation of the pituitary-thyroid axis in man: relationship of TSH concentration to concentration of free and total thyroxine in plasma. J Clin Endocrinol Metab (1967) 1.19
Antidiuretic principle in malignant tumor extracts from patients with inappropriate ADH syndrome. J Clin Endocrinol Metab (1968) 1.17
Iodothyronine metabolism in liver and kidney homogenates from hyperthyroid and hypothyroid rats. Endocrinology (1978) 1.16
Serum thyrotropin and thyroxine concentrations in patients recieving lithium carbonate. J Clin Endocrinol Metab (1973) 1.12
Immunochemical studies with lysine vasopressin. Endocrinology (1966) 1.12
Hyperthyroidism in Tasmania following iodide supplementation: measurements of thyroid-stimulating autoantibodies and thyrotropin. J Clin Endocrinol Metab (1975) 1.11
Prolactin response to thyrotropin releasing hormone in normal subjects. J Clin Endocrinol Metab (1973) 1.10
Estimation of the secretion rate of thyrotropin in man. J Clin Invest (1967) 1.09
Attempts to augment thyrotropin secretion. Effects of methimazole, methimazole-iodide, vasopressin, and glucagon. Metabolism (1970) 1.08
Effect of tri-iodothyronine replacement on the metabolic and pituitary responses to starvation. N Engl J Med (1979) 1.08
Serum thyroid hormone and thyrotropin concentrations during thyroxine and triiodothyronine therapy. J Clin Endocrinol Metab (1974) 1.05
A pill for impotence. N Engl J Med (1998) 1.04
The preparation and specificity of antibody to thyrotropin releasing hormone. Endocrinology (1972) 1.04
Thyroid function and metabolic state in chronic renal failure. Ann Intern Med (1976) 1.03
Altered thyroid function in nonthyroidal illness and surgery. To treat or not to treat? N Engl J Med (1995) 1.03
Hypothalamic endocrinopathy in Hand-Schüller-Christian disease. Ann Intern Med (1978) 1.02
Immunoassay studies of thyrotropin in rat pituitary glands and serum. Endocrinology (1967) 1.02
Changes in serum 3,3',5'-triiodothyronine (reverse T3) concentrations with altered thyroid hormone secretion and metabolism. J Clin Endocrinol Metab (1977) 1.01
Triiodothyronine in cord serum. J Pediatr (1973) 1.01
Ectopic hyperparathyroidism in a patient with metastatic hypernephroma. Metabolism (1973) 1.01
Thyrotrophin radioimmunoassay: another test of thyroid function. Ann Intern Med (1971) 1.01
Low serum triiodothyronine in patients with anorexia nervosa. J Clin Endocrinol Metab (1975) 0.98
Thyrotropin-releasing hormone in the hypothalamus of the rat. Endocrinology (1974) 0.98
Hypothalamic stimulation of growth hormone and thyrotropin lease in vitro and pituitary 3'5'-adenosine cyclic monophosphate. Endocrinology (1970) 0.98
Diagnostic value of thyrotrophin-releasing hormone in pituitary and hypothalamic diseases. Assessment of thyrotrophin and prolactin secretion in 100 patients. Ann Intern Med (1974) 0.98
Regulation of the conversion of thyroxine to triiodothyronine in the perfused rat liver. J Clin Invest (1979) 0.98
Thyroid hormone inhibition of the prolactin response to thyrotropin-releasing hormone. J Clin Invest (1973) 0.97
Metastatic choriocarcinoma associated with hyperthyroidism. J Clin Endocrinol Metab (1970) 0.94
Thyrotropin secretion in genetically obese rats. Endocrinology (1972) 0.92
Failure of retro-orbital tissue to neutralize the biological activity of the long-acting thyroid stimulator. J Clin Endocrinol Metab (1968) 0.91
In vitro studies on mechanism of action of thyrotropin releasing factor. Proc Soc Exp Biol Med (1968) 0.91
Serum triiodothyronine in man. Annu Rev Med (1974) 0.91
Augmentation of thyrotropin responses to thyrotropin-releasing hormone following small decreases in serum thyroid hormone concentrations. J Clin Endocrinol Metab (1975) 0.90
Serum thyroxine and triiodothyronine concentrations during iodide treatment of hyperthyroidism. J Clin Endocrinol Metab (1975) 0.90
Serum inactivation of the immunological and biological activity of thyrotropin releasing hormone (TRH). Endocrinology (1972) 0.90
Thyrotropin-releasing hormone (TRH) in rat spinal cord. Brain Res (1977) 0.90
Neutralization of the long-acting thyroid stimulator by thyroid subcellular fractions. J Lab Clin Med (1967) 0.89
Myxedema coma during long-term amiodarone therapy. Am J Med (1984) 0.88
Effect of central cooling in man on pituitary-thyroid function and growth hormone secretion. J Appl Physiol (1966) 0.88
Thyrotropin release in vitro: stimulation by cyclic 3',5'-Adenosine monophosphate. Endocrinology (1969) 0.87
Medullary thyroid carcinoma, genes, and the prevention of cancer. N Engl J Med (1994) 0.87
Lack of T-cell immune abnormalities in peripheral blood lymphocytes in patients with Graves' disease or hypothyroidism. J Clin Endocrinol Metab (1975) 0.86
Decreased extrathyroidal triiodothyronine production in nonthyroidal illness: benefit or harm? Am J Med (1980) 0.86
Subclinical thyrotoxicosis. Endocrinol Metab Clin North Am (1998) 0.86
Effects of low dose oral iodide supplementation on thyroid function in normal men. Clin Endocrinol (Oxf) (1988) 0.85
Treatment of Graves' ophthalmopathy. N Engl J Med (1989) 0.85
Subclinical hyperthyroidism--just a low serum thyrotropin concentration, or something more? N Engl J Med (1994) 0.84
Insulin and the polycystic ovary syndrome. N Engl J Med (1996) 0.84
Cigarette smoking and the thyroid. N Engl J Med (1995) 0.83
Growth hormone secretion and plasma somatomedin-C in primary hypothyroidism. Clin Endocrinol (Oxf) (1983) 0.83
Serum LH and FSH responses to synthetic gonadotropin-releasing hormone in normal men. J Clin Endocrinol Metab (1975) 0.83
Thyrotropin-releasing hormone content of rat brain and hypothalamus: results of endocrine and pharmacologic treatments. Endocrinology (1977) 0.82
Effects of hypoxia on thyroid function tests. J Pediatr (1980) 0.82
Peripheral resistance to thyroid hormone in an infant. J Clin Endocrinol Metab (1981) 0.81
Inhibition of thyrotropin releasing hormone-mediated secretion of thyrotropin by human growth hormone. J Clin Endocrinol Metab (1973) 0.81
Estrogen, thyroxine binding in serum, and thyroxine therapy. N Engl J Med (2001) 0.81
Effects on the pituitary-thyroid axis and prolactin secretion of single and repetitive oral doses of thyrotropin-releasing hormone (TRH). J Clin Endocrinol Metab (1974) 0.81
Plasma triiodothyronines in fetal sheep: effects of illness and thyroidectomy. Horm Metab Res (1979) 0.80
Thyroid function tests in patients with acute and resolved hepatitis B virus infection. Ann Intern Med (1982) 0.80
Follow-up of patients with thyroid carcinoma. N Engl J Med (1997) 0.80
Melatonin--the hormone of darkness. N Engl J Med (1992) 0.80
Surge of fetal plasma triiodothyronine before birth in sheep. Am J Obstet Gynecol (1978) 0.80
Amenorrhea-galactorrhea, hyperprolactinemia, and suprasellar pituitary enlargement as presenting features of primary hypothyroidism. Obstet Gynecol (1984) 0.80
Age, sex, and serum thyrotropin concentrations in primary hypothyroidism. Acta Endocrinol (Copenh) (1991) 0.79
The pathogenesis of autoimmune thyroid disease. N Engl J Med (1991) 0.79
Effect of hypothalamic deafferentation on thyrotropin-releasing hormone levels in rat brain. Proc Natl Acad Sci U S A (1975) 0.79
Diagnosis of hyperthyroidism. Clin Endocrinol Metab (1978) 0.79
Metabolism and excretion of exogenous thyrotropin-releasing hormone in humans. J Clin Invest (1973) 0.78
The ophthalmopathy of Graves' disease. Annu Rev Med (1992) 0.78
Repetitive administration of thyrotropin-releasing hormone results in small elevations of serum thyroid hormones and in marked inhibition of thyrotropin response. J Clin Invest (1973) 0.78
Effects of oral erythrosine (2',4',5',7'-tetraiodofluorescein) on thyroid function in normal men. Toxicol Appl Pharmacol (1987) 0.78
Reverse triiodothyronine does not alter pituitary-thyroid function in normal subjects. J Clin Endocrinol Metab (1984) 0.78
Thyrotropin-releasing hormone provokes abnormal follicle-stimulating hormone (FSH) and luteinizing hormone responses in men who have pituitary adenomas and FSH hypersecretion. J Clin Endocrinol Metab (1980) 0.78
Abnormalities in thyroid function tests in patients admitted to medical service. Arch Intern Med (1982) 0.78
Plasma thyrotropin-releasing hormone concentrations in the rat. Effect of thyroid excess and deficiency and cold exposure. J Clin Invest (1975) 0.78
Pathogenesis of Graves' ophthalmopathy. N Engl J Med (1992) 0.78
Plasma clearance and plasma half-disappearance time of exogenous thyrotropin-releasing hormone and pyroglutamyl-N3im-methyl-histidyl prolineamide. J Clin Endocrinol Metab (1979) 0.77
Hormones in human pituitary sinusoid blood: concentration of LH, GH and TSH. J Clin Endocrinol Metab (1969) 0.77
Thyrotropin-receptor mutations and thyroid dysfunction. N Engl J Med (1995) 0.77
The effects of 6-hydroxydopamine on thyrotropin-releasing hormone in rat brain. Brain Res (1978) 0.77